Baltimore, MD, United States of America

Kirsten Greene


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kirsten Greene: Innovator in Autoimmune Disease Treatment

Introduction

Kirsten Greene is a notable inventor based in Baltimore, MD (US). She has made significant contributions to the field of autoimmune disease treatment through her innovative research and patent.

Latest Patents

Kirsten Greene holds a patent for "Antigen-based heteropolymers and method for treating autoimmune diseases." This patent involves constructs consisting of antigen-based heteropolymers (AHP's) that include at least one monoclonal antibody specific for binding to the complement receptor (CR1) site on human or non-human primate erythrocytes. The anti-CR1 monoclonal antibody is crosslinked to an antigen specific for a target pathogenic autoantibody. The method provided in the patent aims to treat autoimmune diseases in both human and non-human primates using the AHP.

Career Highlights

Kirsten Greene is affiliated with the University of Virginia, where she continues her research and development in the field of immunology. Her work has garnered attention for its potential impact on treating autoimmune conditions.

Collaborations

Kirsten has collaborated with esteemed colleagues, including Ronald P. Taylor and Polly J. Ferguson, who have contributed to her research endeavors.

Conclusion

Kirsten Greene's innovative work in developing antigen-based heteropolymers represents a significant advancement in the treatment of autoimmune diseases. Her contributions to science and medicine continue to inspire future research in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…